Related Experiment Video
Updated: Mar 23, 2026

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples
Published on: June 6, 2025
End TB strategy: the need to reduce risk inequalities
M Gabriela M Gomes1,2,3, Maurício L Barreto4,5, Philippe Glaziou6
1Liverpool School of Tropical Medicine, Liverpool, UK. Gabriela.Gomes@lstmed.ac.uk.
Individual differences in disease risk significantly impact population health. Ignoring this variability underestimates disease risk and intervention effectiveness, highlighting the need to address inequality for better public health outcomes.
Area of Science:
- Epidemiology
- Public Health
- Mathematical Modeling
Background:
- Diseases manifest in populations with diverse individual characteristics affecting disease dynamics.
- Key individual variations include exposure, susceptibility, and infectiousness.
Purpose of the Study:
- To highlight the impact of individual heterogeneity on disease risk estimation.
- To analyze the implications for human tuberculosis control strategies.
- To demonstrate how reducing risk variability enhances intervention efficacy.
Main Methods:
- Review of demographic concepts on individual variability.
- Analysis of global human tuberculosis incidence data.
- Modeling the impact of interventions under varying risk distributions.
Main Results:
- Ignoring individual heterogeneity leads to underestimation of population disease risk.
- Interventions are most effective in populations with uniform risk exposure.
- Lowering risk inequality significantly amplifies the impact of public health interventions.
Conclusions:
- Demographic principles underscore the critical role of individual variability in disease risk assessment.
- Addressing inequality in disease risk is crucial for optimizing public health interventions and improving population health.
- Reducing health disparities creates a virtuous cycle of improved health and further inequality reduction.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Venous Thrombosis III: Interprofessional Care
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

